PEG-hirudin/iloprost Coating of Small Diameter ePTFE Grafts Effectively Prevents Pseudointima and Intimal Hyperplasia Development

European Journal of Vascular and Endovascular Surgery

Volumn 32, Issue 4, 2006, Pages 418-424

  Heise, M ^a   Schmidmaier, G ^a   Husmann, I ^a   Heidenhain, C ^a   Schmidt, J ^a   Neuhaus, P ^a   Settmacher, U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antithrombotic coating; Hirudin; Iloprost; Intimal hyperplasia; Peripheral grafts

Indexed keywords

HIRUDIN; ILOPROST; LEPIRUDIN; MACROGOL; POLYLACTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ANASTOMOSIS; ARTERY BLOOD FLOW; ARTERY GRAFT; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; FLOW RATE; FOLLOW UP; GRAFT PATENCY; HISTOPATHOLOGY; NONHUMAN; POLITEF IMPLANT; POPLITEAL ARTERY; PRIORITY JOURNAL; SWINE; VASCULAR PATENCY;

ANASTOMOSIS, SURGICAL; ANIMALS; BLOOD FLOW VELOCITY; BLOOD VESSEL PROSTHESIS; COATED MATERIALS, BIOCOMPATIBLE; FEMORAL ARTERY; FIBRINOLYTIC AGENTS; HIRUDINS; HYPERPLASIA; ILOPROST; POLYESTERS; POLYTETRAFLUOROETHYLENE; POPLITEAL ARTERY; SUS SCROFA; TUNICA INTIMA; VASCULAR PATENCY;

EID: 33748446975     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.03.002     Document Type: Article

References (38)

1. Sayers R.D., Raptis S., Berce M., et al. Long-term results of femorotibial bypass with vein or polytetrafluoroethylene. Br J Surg 85 7 (Jul 1998) 934-938
2. Mamode N., and Scott R.N. Graft type for femoro-popliteal bypass surgery. Cochrane Database Syst Rev. 2 (2000) CD001487
3. Sottiurai V.S., Yao J.S., Flinn W.R., et al. Intimal hyperplasia and neointima: An ultrastructural analysis of thrombosed grafts in humans. Surgery 93 6 (Jun 1983) 809-817
4. Imparato A.M., Bracco A., Kim G.E., et al. Intimal and neointimal fibrous proliferation causing failure of arterial reconstructions. Surgery 72 6 (Dec 1972) 1007-1017
5. Clagett G.P., Sobel M., Jackson M.R., et al. Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 3 Suppl (Sep 2004) 609S-626S
6. Jackson M.R., Johnson W.C., Williford W.O., et al. The effect of anticoagulation therapy and graft selection on the ischemic consequences of femoropopliteal bypass graft occlusion: results from a multicenter randomized clinical trial. J Vasc Surg 35 2 (Feb 2002) 292-298
7. Pumphrey C.W., Chesebro J.H., Dewanjee M.K., et al. In vivo quantitation of platelet deposition on human peripheral arterial bypass grafts using indium-111-labeled platelets. Effect of dipyridamole and aspirin. Am J Cardiol 51 5 (Mar 1 1983) 796-801
8. Goldman M.D., Simpson D., Hawker R.J., et al. Aspirin and dipyridamole reduce platelet deposition on prosthetic femoro-popliteal grafts in man. Ann Surg 198 6 (Dec 1983) 713-716
9. Rashid S.T., Salacinski H.J., Fuller B.J., et al. Engineering of bypass conduits to improve patency. Cell Prolif 37 5 (Oct 2004) 351-366
10. Aldenhoff Y.B., van Der Veen F.H., ter Woorst J., et al. Performance of a polyurethane vascular prosthesis carrying a dipyridamole (Persantin) coating on its lumenal surface. J Biomed Mater Res. 54 2 (Feb 2001) 224-233
11. Salacinski H.J., Tiwari A., Hamilton G., et al. Cellular engineering of vascular bypass grafts: role of chemical coatings for enhancing endothelial cell attachment. Med Biol Eng Comput. 39 6 (Nov 2001) 609-618
12. Meinhart J.G., Deutsch M., Fischlein T., et al. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann Thorac Surg 71 5 Suppl (May 2001) S327-S331
13. Devine C., and McCollum C. Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial. J Vasc Surg 40 5 (Nov 2004) 924-931
14. Calaitges J.G., Liem T.K., Spadone D., et al. The role of heparin-associated antiplatelet antibodies in the outcome of arterial reconstruction. J Vasc Surg 29 5 (May 1999) 779-785 discussion 785-776
15. Curi M.A., Skelly C.L., Baldwin Z.K., et al. Long-term outcome of infrainguinal bypass grafting in patients with serologically proven hypercoagulability. J Vasc Surg 37 2 (Feb 2003) 301-306
16. Donaldson M.C., Weinberg D.S., Belkin M., et al. Screening for hypercoagulable states in vascular surgical practice: a preliminary study. J Vasc Surg 11 6 (Jun 1990) 825-831
17. Alt E., and Seliger C. Antithrombotic stent coatings: hirudin/iloprost combination. Semin Interv Cardiol 3 3-4 (Sep-Dec 1998) 177-183
18. Grant S.M., and Goa K.L. Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures. Drugs 43 6 (Jun 1992) 889-924
19. Heise M., Kruger U., Pfitzmann R., et al. The influence of intraarterial prostaglandin E(1) on vascular hydraulic impedance and infrainguinal graft patency. Eur J Vasc Endovasc Surg 22 3 (Sep 2001) 219-225
20. Kruger U., Scholz H., Heise M., et al. Effect of intravenous iloprost and alprostadil (PGE1) on peripheral resistance during femoro-distal reconstructions. Int Angiol 19 4 (Dec 2000) 358-365
21. Herrmann R., Schmidmaier G., Markl B., et al. Antithrombogenic coating of stents using a biodegradable drug delivery technology. Thromb Haemost 82 1 (Jul 1999) 51-57
22. Ducasse E., Fleurisse L., Vernier G., et al. Interposition vein cuff and intimal hyperplasia: an experimental study. Eur J Vasc Endovasc Surg 27 6 (Jun 2004) 617-621
23. Kissin M., Kansal N., Pappas P.J., et al. Vein interposition cuffs decrease the intimal hyperplastic response of polytetrafluoroethylene bypass grafts. J Vasc Surg 31 1 Pt 1 (Jan 2000) 69-83
24. Karges H.E., Funk K.A., and Ronneberger H. Activity of coagulation and fibrinolysis parameters in animals. Arzneimittelforschung 44 6 (Jun 1994) 793-797
25. Seifalian A.M., Tiwari A., Hamilton G., et al. Improving the clinical patency of prosthetic vascular and coronary bypass grafts: the role of seeding and tissue engineering. Artif Organs 26 4 (Apr 2002) 307-320
26. Kidane A.G., Salacinski H., Tiwari A., et al. Anticoagulant and antiplatelet agents: their clinical and device application(s) together with usages to engineer surfaces. Biomacromolecules 5 3 (May-Jun 2004) 798-813
27. Devine C., Hons B., and McCollum C. Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicenter trial. J Vasc Surg 33 3 (Mar 2001) 533-539
28. Walpoth B.H., Rogulenko R., Tikhvinskaia E., et al. Improvement of patency rate in heparin-coated small synthetic vascular grafts. Circulation 98 19 Suppl (Nov 10 1998) II319-II323 [discussion II324]
29. Cruz D., Karlsberg R., Takano Y., et al. Subacute stent thrombosis associated with a heparin-coated stent and heparin-induced thrombocytopenia. Catheter Cardiovasc Interv 58 1 (Jan 2003) 80-83
30. Schmidmaier G., Wildemann B., Stemberger A., et al. Biodegradable poly(D,L-lactide) coating of implants for continuous release of growth factors. J Biomed Mater Res. 58 4 (2001) 449-455
31. Alt E., Haehnel I., Beilharz C., et al. Inhibition of neointima formation after experimental coronary artery stenting: a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost. Circulation 101 12 (Mar 28 2000) 1453-1458
32. Kelly A.B., Marzec U.M., Krupski W., et al. Hirudin interruption of heparin-resistant arterial thrombus formation in baboons. Blood 77 5 (Mar 1 1991) 1006-1012
33. Esslinger H.U., Haas S., Maurer R., et al. Pharmacodynamic and safety results of PEG-Hirudin in healthy volunteers. Thromb Haemost 77 5 (May 1997) 911-919
34. Bossavy J.P., Sakariassen K.S., Rubsamen K., et al. Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis. Arterioscler Thromb Vasc Biol. 19 5 (May 1999) 1348-1353
35. Gallo R., Padurean A., Toschi V., et al. Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries. Circulation 97 6 (Feb 17 1998) 581-588
36. Knudtson M.L., Flintoft V.F., Roth D.L., et al. Effect of short-term prostacyclin administration on restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 15 3 (Mar 1 1990) 691-697
37. Bassiouny H.S., White S., Glagov S., et al. Anastomotic intimal hyperplasia: mechanical injury or flow induced. J Vasc Surg 15 4 (Apr 1992) 708-716 [discussion 716-707]
38. Heise M., Kruger U., Ruckert R., et al. Correlation of intimal hyperplasia development and shear stress distribution at the distal end-side-anastomosis, in vitro study using particle image velocimetry. Eur J Vasc Endovasc Surg 26 4 (Oct 2003) 357-366